Food and Drug Administration - Search News

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

Time on MSN · 28m

FDA Approves the First Non-Opioid Pain Drug in 20 Years

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non-opioid painkiller since that class first appeared on the market in the 1980s.

FDA approves new painkiller that shows promise and challenges of opioid alternatives

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids. The Food and Drug Administration approved the pill from Vertex Pharmaceuticals for acute pain that often occurs after surgery or injuries.

Vertex wins FDA approval for non-opioid pain drug, setting stage for closely watched rollout

Vertex Pharmaceuticals on Thursday won approval from the Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and mixed opinions among physicians and market analysts.

Lay's Potato Chip Recall Is Very Serious

USA TODAY on MSN · 1d

FDA upgrades Frito-Lay potato chips recall to highest risk level due to undeclared milk

Federal regulators have upgraded a product recall of Lay's Classic Potato Chips to the highest risk level for a batch that may contain undeclared milk ingredients. Last month, Frito-Lay issued a recall warning that more than 6,

The New York Times · 1d

The F.D.A. Upgraded a Recall of Some Lay’s Potato Chips. Here’s What to Know.

The Food and Drug Administration is using its most severe notice in a recall of more than 6,000 bags of chips in two states because of “undeclared milk.”

Lay’s recall upgraded to highest risk level

The Food and Drug Administration (FDA) says a previously announced recall of certain bags of Lay’s potato chips in Oregon and Washington now falls into “Class I” status, its highest risk

4h

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

WISH-TV on MSN2h

FDA redefines ‘healthy’ food labels to help consumers make informed choices

The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...

4don MSN

Food and Drug Administration wants to put nutrition labels front and center on food products

The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...

2h

Fact check: Kennedy repeats false and misleading claims in confirmation hearing

In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...

1m

RFK Jr. second hearing takeaways: GOP criticism, more Medicare fumbles, and DEI

RFK Jr.'s second Senate confirmation hearing focused on vaccines, Medicare, diversity, and science. Key Republicans were reticent to show support.

Ozempic And Other GLP-1s Show Promise With 42 Conditions — But There Are Still Big Risks

Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...

7d

Trump Administration Orders a Temporary Freeze on Food and Health Agency Communications

Dr. Dorothy Fink, the acting secretary for the Department of Health and Human Services under President Donald Trump, has ...

3don MSN

US FDA OKs monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug

The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results